The price target set by analysts for Novavax, Inc. (NASDAQ:NVAX) is $14.00
Analysts Set Novavax, Inc. (NASDAQ:NVAX) | Image Credit: marketbeat.com
According to Marketbeat, the five analysts covering Novavax, Inc. (NASDAQ:NVAX) have recommended on average to "Hold" the company's shares. Two equities research experts have recommended that the business purchase the stock, and three have rated it with a hold rating. Brokerages who have rated the stock in the past year have set a 12-month price objective of $14.00 on average.
Recently, several research organisations have provided their opinions on NVAX. In a report released on Monday, TD Cowen raised their price objective for Novavax from $5.00 to $10.00 and recommended that investors "keep" the company. In a research note released on Monday, HC Wainwright maintained a "buy" rating on shares of Novavax and estab...